Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards.

Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards. by Jones RN, Doern GV, Gerlach EH, Hindler J and Erwin ME published in Diagn. Microbiol. Infect. Dis. 1994; 18 (4): 243-249

Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: Real or perceived? Fluoroquinolone Resistance Surveillance Group.

Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: Real or perceived? Fluoroquinolone Resistance Surveillance Group. by Jones RN, Kehrberg EN, Erwin ME and Anderson SC published in Diagn. Microbiol. Infect. Dis. 1994; 19 (4): 203-215

Update of lomefloxacin in vitro activity and spectrum. A multicenter trial testing contemporary pathogens following Food and Drug Administration validation guidelines. Lomefloxacin Activity Study Group.

Update of lomefloxacin in vitro activity and spectrum. A multicenter trial testing contemporary pathogens following Food and Drug Administration validation guidelines. Lomefloxacin Activity Study Group. by Jones RN, Sader HS and Erwin ME published in Diagn. Microbiol. Infect. Dis. 1994; 20 (2): 93-98

Prediction of piperacillin-tazobactam susceptibility among Enterobacteriaceae, Pseudomonas aeruginosa, and other bacteria using ticarcillin-clavulanic acid, ceftazidime, and other broad-spectrum antimicrobial in vitro test results.

Prediction of piperacillin-tazobactam susceptibility among Enterobacteriaceae, Pseudomonas aeruginosa, and other bacteria using ticarcillin-clavulanic acid, ceftazidime, and other broad-spectrum antimicrobial in vitro test results. by Jones RN, Sutton LD, Cantrell HF and Lankford RB published in Diagn. Microbiol. Infect. Dis. 1994; 20 (3): 143-149

Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacin.

Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacin. by Houston AK and Jones RN published in Diagn. Microbiol. Infect. Dis. 1994; 18 (1): 57-59

Predictive accuracy of disk diffusion test for Proteus vulgaris and Providencia species against five newer orally administered cephalosporins, cefdinir, cefetamet, cefprozil, cefuroxime, and loracarbef.

Predictive accuracy of disk diffusion test for Proteus vulgaris and Providencia species against five newer orally administered cephalosporins, cefdinir, cefetamet, cefprozil, cefuroxime, and loracarbef. by Biedenbach DJ and Jones RN published in J. Clin. Microbiol. 1994; 32 (2): 559-562

Oxacillin- and quinolone-resistant Staphylococcus aureus in Sao Paulo, Brazil: A multicenter molecular epidemiology study.

Oxacillin- and quinolone-resistant Staphylococcus aureus in Sao Paulo, Brazil: A multicenter molecular epidemiology study. by Sader HS, Pignatari AC, Hollis RJ, Leme I and Jones RN. published in Infect. Control. Hosp. Epidemiol. 1993; 14 (5): 260-264

Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit.

Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit. by Sader HS, Pignatari AC, Leme IL, Burattini MN, Tancresi R, Hollis RJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 1993; 17 (1): 13-18

In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5,556 recent clinical isolates from five medical centers.

In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5,556 recent clinical isolates from five medical centers. by Sader HS, Jones RN, Washington JA, Murray PR, Gerlach EH, Allen SD and Erwin ME published in Diagn. Microbiol. Infect. Dis. 1993; 17 (2): 143-150

Interlaboratory variations of fluoroquinolone susceptibility testing. An international study to validate the quality of microbiology results reported during the fleroxacin clinical trials.

Interlaboratory variations of fluoroquinolone susceptibility testing. An international study to validate the quality of microbiology results reported during the fleroxacin clinical trials. by Jones RN, Erwin ME, Hager HL and Hohl PE published in Diagn. Microbiol. Infect. Dis. 1993; 17 (3): 225-232